Dow's fair value estimate has recently been adjusted downward from $28.24 to $27.82. This change reflects updated assessments of the company's near-term prospects. The slight reduction captures a more ...

South Korean drugmaker Celltrion Inc said on Friday patients treated with its experimental COVID-19 antibody drug in a small-size early-stage trial showed at least a 44% improvement in recovery time.

Eli Lilly and Co said on Monday its rheumatoid arthritis drug shortened the time to recovery in hospitalized COVID-19 patients when used along with Gilead Sciences Inc's remdesivir.

In a series of announcements made during the past two weeks, Boeing has signaled plans to raise 737 MAX production rates, reported its strongest 737 MAX deliveries since 2018, and secured major new ...